|
Nov 2006
|
Diagnostic Assessment of the Child with Status Epilepticus Note:Current guideline. Clinician summary and patient and caregiver summary available.
|
|
Jul 2006
|
Prediction of Outcome in Comatose Survivors after Cardiopulmonary Resuscitation Note: Current guideline. Clinician summary and patient summary available.
|
|
Sep 2005
|
Use of Serum Prolactin in Diagnosing Epileptic Seizures Note: Current guideline. PowerPoint educational tool and PDA version available.
|
|
Jan 2005
|
Corticosteroid Treatment of Duchenne Dystrophy Note: Reaffirmed on 02/08/2008. Current guideline. Clinician summary, patient and caregiver summary of guideline, and PowerPoint educational tool are available.
|
|
Dec 2004
|
Pharmacological Treatment of Migraine Headache in Children and Adolescents Note: Current guideline. Clinician summary, patient and caregiver summary of guideline, and PowerPoint educational tool are available.
|
|
May 2004
|
Medical Treatment of Infantile Spasms Note: Current guideline. Clinician summary, patient and caregiver summary, and PowerPoint educational tool are available.
|
|
Apr 2004
|
Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy Note: Update in Progress. PowerPoint educational tool, clinician summary, and patient and caregiver summary available.
|
|
Apr 2004
|
Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy Note: Update in progress. PowerPoint educational tool, clinician summary, and patient and caregiver summary available.
|
|
Mar 2004
|
Diagnostic Assessment of the Child with Cerebral Palsy Note: Current guideline. Reaffirmed on 07/21/2007. Clinician summary, patient and caregiver summary, and PowerPoint educational tool are available.
|
|
Sep 2003
|
Immunotherapy for Guillain-Barré Syndrome Note: Current guideline-reaffirmed 10/15/2005. Supplemental data, slide presentation, clinician summary, and patient and caregiver summary available.
|
|
Mar 2003
|
Temporal Lobe and Localized Neocortical Resections for Epilepsy Note: Current guideline-reaffirmed 10/15/2005. Patient and caregiver version and supplemental data available.
|
|
Feb 2003
|
Evaluation of the Child with Global Developmental Delay Note: Current guideline-reaffirmed 10/15/2005. Additional information on recommended tests provided. Clinician summary, patient and caregiver summary, and PowerPoint educational tool available.
|
|
Jan 2003
|
Treatment of the Child with a First Unprovoked Seizure Note: Current guideline-reaffirmed 07/28/2006.
|
|
Aug 2002
|
Evaluation of Children and Adolescents with Recurrent Headache Note: Current guideline-reaffirmed 10/15/2005 and 10/18/2003.
|
|
Jun 2002
|
Neuroimaging of the Neonate Note: Current guideline-reaffirmed 10/15/2005. Supplemental data available.
|
|
Sep 2000
|
Evaluating the First Nonfebrile Seizure in Children Note: Current guideline-reaffirmed 07/28/2006 and 10/18/2003.
|
|
Aug 2000
|
Screening and Diagnosis of Autism Note: Current guideline-reaffirmed 07/28/2006 and 10/18/2003. Early identification and intervention can improve outcomes for toddlers and preschoolers with autism. Clinician summary, patient and caregiver summary, and PowerPoint educational tool are available.
|
|
Mar 1997
|
The Management of Concussion in Sports Note: Update in progress.
|
|
May 1995
|
Assessment and Management of Patients in the Persistent Vegetative State Note: Current guideline-reaffirmed 07/28/2006.
|
|
Patient Summary
|
Diagnostic Assessment of the Child with Status Epilepticus
|
|
Clinician Summary
|
Diagnostic Assessment of the Child with Status Epilepticus
|
|
PDA Version
|
Corticosteroid Treatment of Duchenne Dystrophy
|
|
PDA Version
|
Pharmacological Treatment of Migraine Headache in Children and Adolescents
|
|
Slide Presentation
|
Corticosteroid Treatment of Duchenne Dystrophy Note: PowerPoint presentation based on the corticosteroid treatment of DD guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
|
|
Clinician Summary
|
Corticosteroid Treatment of Duchenne Dystrophy
|
|
Patient Summary
|
Corticosteroid Treatment of Duchenne Dystrophy
|
|
Clinician Summary
|
Pharmacological Treatment of Migraine Headache in Children and Adolescents
|
|
Patient Summary
|
Pharmacological Treatment of Migraine Headache in Children and Adolescents
|
|
Slide Presentation
|
Pharmacological Treatment of Migraine Headache in Children and Adolescents Note: PowerPoint presentation based on the pharmacological treatment of migraine headache in children and adolescents guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
|
|
Slide Presentation
|
Medical Treatment of Infantile Spasms Note: PowerPoint presentation based on the Medical Treatment of Infantile Spasms guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
|
|
Clinician Summary
|
Medical Treatment of Infantile Spasms
|
|
Patient Summary
|
Medical Treatment of Infantile Spasms
|
|
Slide Presentation
|
Diagnostic Assessment of the Child with Cerebral Palsy Note: PowerPoint presentation based on the Diagnostic assessment of the child with cerebral palsy guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
|
|
Patient Summary
|
Diagnostic Assessment of the Child with Cerebral Palsy
|
|
Clinician Summary
|
Diagnostic Assessment of the Child with Cerebral Palsy
|
|
Slide Presentation
|
Evaluation of the Child with Global Developmental Delay Note: PowerPoint presentation based on the Evaluation of the child with global developmental delay guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
|
|
Clinician Summary
|
Evaluation of the Child with Global Developmental Delay
|
|
Patient Summary
|
Evaluation of the Child with Global Developmental Delay
|
|
Background/Data
|
Global Developmental Delay Appendix Note: Information regarding selected tests.
|
|
Background/Data
|
Neuroimaging of the Neonate Background Data Note: Supplemental data.
|
|
Patient Summary
|
Screening and Diagnosis of Autism
|
|
Slide Presentation
|
Screening and Diagnosis of Autism Note: PowerPoint presentation based on the Screening and diagnosis of autism guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
|
|
Clinician Summary
|
Screening and Diagnosis of Autism
|
|
back to top
|
|
Nov 2007
|
Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review) Note:Current guideline. Clinician summary and Patient and Caregiver summary available.
|
|
Oct 2007
|
Reassessment: Neuroimaging in the Emergency Patient Presenting with Seizure Note:Current guideline. Clinician Summary and Case Study available.
|
|
Sep 2005
|
Use of Serum Prolactin in Diagnosing Epileptic Seizures Note: Current guideline. PowerPoint educational tool and PDA version available.
|
|
Apr 2004
|
Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy Note: Update in Progress. PowerPoint educational tool, clinician summary, and patient and caregiver summary available.
|
|
Apr 2004
|
Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy Note: Update in progress. PowerPoint educational tool, clinician summary, and patient and caregiver summary available.
|
|
Mar 2003
|
Temporal Lobe and Localized Neocortical Resections for Epilepsy Note: Current guideline-reaffirmed 10/15/2005. Patient and caregiver version and supplemental data available.
|
|
Jan 2003
|
Treatment of the Child with a First Unprovoked Seizure Note: Current guideline-reaffirmed 07/28/2006.
|
|
Sep 2000
|
Evaluating the First Nonfebrile Seizure in Children Note: Current guideline-reaffirmed 07/28/2006 and 10/18/2003.
|
|
Sep 1999
|
Reassessment: Vagus Nerve Stimulation for Epilepsy (UPDATED) Note: Guideline under update. Guideline was reaffirmed on 10/17/2003.
Supplement to Assessment of vagus nerve stimulation for epilepsy (07/1997).
|
|
May 1999
|
The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy Note:Current guideline. Reaffirmed 10/28/2006 and 10/18/2003.
|
|
Oct 1998
|
Management Issues for Women with Epilepsy Note: Update in progress. Clinician summary available.
|
|
Jul 1997
|
Digital EEG, Quantitative EEG, and EEG Brain Mapping Note: Current guideline-reaffirmed on 12/09/2006 and 10/17/2003.
Replaces Assessment of digital EEG, quantitative EEG, and EEG brain mapping (08/1989).
|
|
Jul 1997
|
Assessment of Vagus Nerve Stimulation for Epilepsy Note: Supplemented by Reassessment: Vagus nerve stimulation for epilepsy (1999)
|
|
Case Study
|
Case Study: Evaluating an Apparent Unprovoked First Seizure in Adults and Coding
|
|
Patient Summary
|
Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review)
|
|
Clinician Summary
|
Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review)
|
|
Background/Data
|
Case Study - Reassessment: Neuroimaging in the Emergency Patient Presenting with Seizure
|
|
Clinician Summary
|
Reassessment: Neuroimaging in the Emergency Patient Presenting with Seizure
|
|
PDA Version
|
Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment of Refractory Epilepsy
|
|
PDA Version
|
Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy
|
|
PDA Version
|
Use of Serum Prolactin in Diagnosing Epileptic Seizures
|
|
Slide Presentation
|
Use of Serum Prolactin in Diagnosing Epileptic Seizures
|
|
Slide Presentation
|
Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy Note: PowerPoint presentation based on the AED for treatment of new onset epilepsy guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
|
|
Slide Presentation
|
Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy Note: PowerPoint presentation based on the AED for treatment of refractory epilepsy guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
|
|
Patient Summary
|
Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy
|
|
Clinician Summary
|
Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy
|
|
Patient Summary
|
Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy
|
|
Patient Summary
|
Treatments for Refractory Epilepsy: Anti-Epileptic Drugs; Temporal Lobe Localized Neocortical Resections; Vagus Nerve Stimulation
|
|
Clinician Summary
|
Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy
|
|
Clinician Summary
|
Treatments for Refractory Epilepsy: Anti-Epileptic Drugs; Temporal Lobe Localized Neocortical Resections
|
|
Background/Data
|
Temporal Lobe and Localized Neocortical Resections for Epilepsy Note: Supplemental data.
|
|
Clinician Summary
|
Management Issues for Women with Epilepsy
|
|
back to top
|
|
Apr 2006
|
Neuroprotective strategies and alternative therapies for Parkinson disease Note:Current guideline. Slide presentation and PDA version of guideline available.
|
|
Apr 2006
|
Treatment of Parkinson disease with motor fluctuations and dyskinesias Note:Current guideline. Slide presentation, patient and caregiver summary, clinician summary and PDA version of guideline available.
|
|
Apr 2006
|
Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease Note:Current guideline. Slide presentation, patient and caregiver summary, clinician summary and PDA version of guideline available.
|
|
Apr 2006
|
Diagnosis and prognosis of new onset Parkinson disease Note:Current guideline. Slide presentation, patient and caregiver summary, clinician summary and PDA version of guideline available.
|
|
Jun 2005
|
Therapies for Essential Tremor Note: Current guideline. Clinician summary, patient and caregiver summary, slide presentation and PDA version of guideline available.
|
|
Jan 2002
|
Initiation of Treatment for Parkinson's Disease (UPDATED) Note: Current guideline-reaffirmed 10/15/2005 and 10/18/2003. Replaces Practice Parameters: Initial therapy of Parkinson's disease (Summary Statement) 7/1993. PDA version of guideline available.
|
|
Slide Presentation
|
Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesia with Audio
|
|
Slide Presentation
|
Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesia without Audio
|
|
Clinician Summary
|
Diagnosis, Prognosis, Neuroprotection, Initiation of Treatment, and Alternative Therapies for Parkinson Disease
|
|
Slide Presentation
|
Diagnosis and Prognosis of New Onset Parkinson Disease
|
|
Patient Summary
|
Diagnosis, Prognosis, and Treatments for Newly Diagnosed Parkinson Disease
|
|
Slide Presentation
|
Neuroprotective Strategies and Alternative Therapies for Parkinson Disease
|
|
Clinician Summary
|
Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease
|
|
Patient Summary
|
Medical and Surgical Treatment for Motor Fluctuations and Dyskinesia in Parkinson Disease
|
|
Clinician Summary
|
Medical and Surgical Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesia
|
|
Patient Summary
|
Screening and Treatment for Depression, Dementia, and Psychosis in Parkinson Disease
|
|
Slide Presentation
|
Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease
|
|
PDA Version
|
Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesia
|
|
PDA Version
|
Diagnosis and Prognosis of New Onset Parkinson Disease
|
|
PDA Version
|
Evaluation Treatment of Depression, Psychosis and Dementia in Parkinson Disease
|
|
PDA Version
|
Neuroprotective Strategies and Alternative Therapies for Parkinson Disease
|
|
PDA Version
|
Initiation of Treatment for Parkinson’s Disease
|
|
PDA Version
|
Therapies for Essential Tremor
|
|
Patient Summary
|
Therapies for Essential Tremor
|
|
Clinician Summary
|
Therapies for Essential Tremor
|
|
Slide Presentation
|
Therapies for Essential Tremor
|
|
back to top
|
|
Feb 2008
|
Practice Parameter: Assessing patients in a neurology practice for risk of falls (an evidence-based review) Note:Current guideline. Clinician summary , Patient and Caregiver summary, Case Study and Coding and Slide Presentation available.
|
|
May 2007
|
Treatment of Nervous System Lyme Disease Note:Current guideline. Clinician summary, patient and caregiver summary, Case Study, and slide presentation are available.
|
|
Apr 2007
|
The medical treatment of ocular myasthenia (an evidence-based review) Note: Current guideline. Background data available.
|
|
Mar 2007
|
Assessment: Use of epidural steroid injections to treat radicular lumbosacral pain Note:Current Guideline. Clinician summary, patient summary, and slide presentation available.
|
|
Aug 2005
|
Addendum to Assessment: Prevention of post-lumbar puncture headaches Note: Current guideline. Reaffirmed on 02/09/2008. See Addendum to Prevention of Post-lumbar Puncture Headache (10/2000). PDA version available.
|
|
Jan 2005
|
Distal Symmetric Polyneuropathy: A Definition for Clinical Research Note: Reaffirmed on 02/08/2008. Current case definition.
|
|
Sep 2004
|
Treatment of Postherpetic Neuralgia Note: Current guideline. Reaffirmed on 02/08/2008. Clinician summary, patient and caregiver summary of guideline, and slide presentation are available.
|
|
Apr 2001
|
Steroids, Acyclovir, and Surgery for Bell's Palsy Note: Under update. This guideline was reaffirmed on 2/13/2004.
|
|
Oct 2000
|
Prevention of Post-Lumbar Puncture Headache Note: See Addendum: Prevention of post-lumbar puncture headaches 08/2005.
|
|
Jul 2000
|
Thymectomy for Autoimmune Myasthenia Gravis Note: Current guideline. Reaffirmed 10/28/2006 and 10/18/2003.
|
|
May 2000
|
Anticonvulsant Prophylaxis in Patients with Newly Diagnosed Brain Tumors Note: Current guideline-reaffirmed 10/18/2003.
|
|
May 1999
|
Neurologic Risk of Immunization Note: Update in progress. Replaces Assessment DTP vaccination (03/1992).
|
|
Jan 1998
|
Evaluation and Management of Intracranial Mass Lesions in AIDS Note:Current guideline-reaffirmed on 01/13/2007 and 10/18/2003.
|
|
Jun 1997
|
Silicon Breast Implants and Neurologic Disorders Note: Current guideline-reaffirmed on 03/31/2007 and 10/23/2005.
|
|
Nov 1996
|
Genetic Testing Alert Note: Current guideline.
|
|
Mar 1996
|
Diagnosis of Patients with Nervous System Lyme Borreliosis (Lyme Disease) Note: Current guideline. Reaffirmed 10/28/2006 and 10/18/2003.
|
|
Dec 1995
|
Neurological Evaluation of Male Sexual Dysfunction Note: Update in progress.
|
|
Apr 1994
|
Magnetic Resonance Imaging in the Evaluation of Low-Back Syndrome Note: Current guideline. Reaffirmed on 07/24/2004.
|
|
Mar 1994
|
Melodic Intonation Therapy Note:Update in progress 12/09/2006.
Current guideline-reaffirmed 10/17/2003.
|
|
Feb 1992
|
Techniques in the Diagnosis and Management of Sleep Disorders Note: Update in progress.
|
|
Sep 1990
|
Botulinum Toxin-A in Treating Neurologic Disorders Note: Update in progress and not available to download at this time.
|
|
Case Study
|
Case Study: Risk of Falls,Coding and Patient Safety Tip
|
|
Clinician Summary
|
Assessing Patients In A Neurology Practice For Risk Of Falls
|
|
Patient Summary
|
Assessing Your Risk For Falls
|
|
Slide Presentation
|
Assessing Patients In A Neurology Practice For Risk Of Falls
|
|
Clinician Summary
|
Use of epidural steroid injections to treat radicular lumbosacral pain
|
|
Patient Summary
|
Use of epidural steroid injections to treat radicular lumbosacral pain
|
|
Slide Presentation
|
Treatment of Nervous System Lyme Disease
|
|
Case Study
|
Lyme Disease Case Study: Treatment & Coding Note:Case presentation on the Treatment and Coding of Nervous System Lyme Disease
|
|
Patient Summary
|
Treatment of Nervous System Lyme Disease
|
|
Clinician Summary
|
Treatment of Nervous System Lyme Disease
|
|
Background/Data
|
The medical treatment of ocular myasthenia (an evidence-based review)
|
|
Slide Presentation
|
Use of epidural steroid injections to treat radicular lumbosacral pain Note:Current guideline. Clinician summary, patient summary, and slide presentation are available.
|
|
Clinician Summary
|
Treatment of Postherpetic Neuralgia
|
|
Patient Summary
|
Treatment of Postherpetic Neuralgia
|
|
Slide Presentation
|
Treatment of Posthepetic Neuralgia Note: PowerPoint presentation based on the treatment of postherptic neuralgia guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
|
|
back to top
|
|
|
Guideline Tools
This CD-ROM contains a variety of guideline companion tools, including:
Patient/Caregiver Guideline Summaries
Use the patient/caregiver summaries to describe to your patients and their families how you will diagnose, evaluate, and treat their condition based on the evidence. Print and duplicate as needed to share with patients and place in your office or waiting room.
Clinician Guideline Summaries
Clinician summaries conveniently provide essential information from the guideline. Refer to the clinician summary when making diagnosis and treatment decisions. Print clinician summaries and keep them handy for quick and easy reference.
Presentation Tools
Share presentations based on practice guideline evidence with your colleagues, at state society meetings, in grand rounds, and with residents and medical students. Insert these slides in your presentations.
Case Studies
Vignettes bring the guidelines to life through tangible examples of clinical scenarios. Included with the cases are coding, billing, and patient safety tips as applicable.
Guideline Purpose & Process
The AAN develops clinical practice guidelines to assist its members in clinical decision making—particularly in situations of controversy or variation in practice.
Most Common Uses for AAN Guidelines:
- Improve health outcomes for patients
- Stay abreast of the latest in clinical research
- Appeal payment denials
- Provide medico-legal protection
- Advocate for fair reimbursement
- Determine whether your practice follows current, best evidence
- Affirm the role of neurologists in the diagnosis and treatment of neurological disorders
- Influence public or hospital policy
- Promote efficient use of resources
- Identify research priorities based on gaps in current literature
- Reduce inappropriate practice variation
Guideline Development Process
The Quality Standards Subcommittee (QSS) develops practice parameters and practice advisories. The Therapeutics and Technology Assessment Subcommittee (TTA) develops technology assessments. Both subcommittees form expert panels to critically assess all of the relevant literature on a given topic or technology. Evidence is rated based on quality of study design, and clinical practice recommendations are developed and stratified to reflect the quality and the content of the evidence.
Key Steps of the Process
- Select guideline topic
- Form panel of experts
- Develop clinical questions
- Comprehensive review of literature
- Summarize findings of evidence
- Make explicit, evidence-based practice recommendations
- Extensive peer review of guideline draft
- AAN approval of guideline
AAN Guidelines Are "Above the Fray"
The editorial below discusses the transparency and rigor of the American Academy of Neurology guideline development process.
Franklin, G.M.; Zahn, C.A. AAN clinical practice guidelines: above the fray.
NEUROLOGY 2002; 59: 975-976.
A Neurologist's Guide to Guidelines
A Neurologist's Guide to Guidelines written by Janis Miyasaki, MD, FAAN and Esther Bui, BSc, MD.
Additional Guideline Resources
Full-text guidelines are also available on the web at www.aan.com or by contacting AAN Member Services at
memberservices@aan.com or (800) 879-1960.
This resource includes guidelines published between January 1995 and February 2008. Please visit the AAN Website for information on guidelines published after February 2008.
The AAN Pocket Guidelines provide concise summaries of AAN guidelines in a pocket-sized book or on PDA. To obtain this invaluable reference please contact
AAN Member Services at memberservices@aan.com or (800) 879-1960 or visit the
AAN Website at www.aan.com.
Adobe Acrobat Reader
Adobe® Acrobat® Reader® is required to view the guidelines. Please visit www.adobe.com to obtain a free version of the software.
|